Nanhua Deng

4.6k total citations · 1 hit paper
10 papers, 3.6k citations indexed

About

Nanhua Deng is a scholar working on Oncology, Immunology and Organic Chemistry. According to data from OpenAlex, Nanhua Deng has authored 10 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Immunology and 2 papers in Organic Chemistry. Recurrent topics in Nanhua Deng's work include Cytokine Signaling Pathways and Interactions (3 papers), Adenosine and Purinergic Signaling (2 papers) and Click Chemistry and Applications (2 papers). Nanhua Deng is often cited by papers focused on Cytokine Signaling Pathways and Interactions (3 papers), Adenosine and Purinergic Signaling (2 papers) and Click Chemistry and Applications (2 papers). Nanhua Deng collaborates with scholars based in United States, Switzerland and Canada. Nanhua Deng's co-authors include Xun Weng, Marlene Dembski, Louis A. Tartaglia, Grayson Richards, A Moriarty, Karen J. Moore, John S. Smutko, René Devos, Jim Deeds and Janice Culpepper and has published in prestigious journals such as Cell, Journal of Clinical Investigation and Cancer Research.

In The Last Decade

Nanhua Deng

10 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification and expression cloning of a leptin receptor, OB-R

1995 2.8k citations Louis A. Tartaglia, Marlene Dembski et al. Cell profile →

Peers

Countries citing papers authored by Nanhua Deng

Since Specialization

Citations

This map shows the geographic impact of Nanhua Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nanhua Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nanhua Deng more than expected).

Fields of papers citing papers by Nanhua Deng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nanhua Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nanhua Deng. The network helps show where Nanhua Deng may publish in the future.

Co-authorship network of co-authors of Nanhua Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Nanhua Deng. A scholar is included among the top collaborators of Nanhua Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nanhua Deng. Nanhua Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Abstract 3751: Inhibition of A2AR by AZD4635 induces anti-tumor immunity alone and in combination with anti-PD-L1 in preclinical models 2018 ·Cancer Research ·Alexandra Borodovsky, Yanjun Wang, Minwei Ye, J.C. Shaw, Kris F. Sachsenmeier, Nanhua Deng, Kelly Goodwin, James Clarke, Richard J. A. Goodwin, Nicole Strittmatter, Carl Hay, Vasu R. Sah, Deborah Lawson, Corinne Reimer, Miles Congreve, Jonathan S. Mason, Fiona H. Marshall, Paul D. Lyne, Richard Woessner	8
2	Abstract 5580: Preclinical pharmacodynamics and antitumor activity of AZD4635, a novel adenosine 2A receptor inhibitor that reverses adenosine mediated T cell suppression 2017 ·Cancer Research ·Alexandra Borodovsky, Yanjun Wang, Minwei Ye, J.C. Shaw, Kris F. Sachsenmeier, Nanhua Deng, (unknown), Adrian J. Fretland, James Clarke, Richard J. A. Goodwin, Nicole Strittmatter, Carl Hay, Vasu R. Sah, (unknown), Corinne Reimer, Miles Congreve, Jonathan S. Mason, Fiona H. Marshall, Paul D. Lyne, Richard Woessner	19
3	Abstract 3684: Inhibition of STAT3 by antisense oligonucleotide treatment decreases the immune suppressive tumor microenvironment in syngeneic and GEM tumor models 2017 ·Cancer Research ·Rich Woessner, Vasu R. Sah, Patricia McCoon, Shaun Grosskurth, Nanhua Deng, Rachel DuPont, Deborah Lawson, Lourdes Pablo, Corinne Reimer, Marco A. De Velasco, Hirotsugu Uemura, Juliana Candido, Paul D. Lyne	1
4	Abstract 4046: Targeting jak/stat adaptive mechanism with jak1 inhibitor azd4205 reduces residual disease and prolongs benefit of osimertinib 2017 ·Cancer Research ·Huawei Chen, Geraldine Bebernitz, Kirsten Bell, Erica Anderson, Nanhua Deng, Jason G. Kettle, Paul D. Lyne, Richard Woessner	2
5	Abstract A94: STAT3 antisense treatment decreases M2 macrophage infiltration and enhances the activity of checkpoint inhibitors in preclinical tumor models 2015 ·Molecular Cancer Therapeutics ·Richard Woessner, Patricia McCoon, Shaun Grosskurth, Paul D. Lyne, Kirsten Bell, Michael P. Collins, Nanhua Deng, Rachel DuPont, Michele Johnstone, Youngsoo Kim, Deborah Lawson, Robert A. MacLeod, Lourdes Pablo, Corinne Reimer, Vasu R. Sah, Margaret H. Veldman-Jones	2
6	Expression of the cysteine protease legumain in vascular lesions and functional implications in atherogenesis 2008 ·Atherosclerosis ·Valérie Clerin, Heather H. Shih, Nanhua Deng, (unknown), Christine Resmini, Kathleen Shields, Jeffrey L. Feldman, Aaron Winkler, Leo Albert, (unknown), Anthony Wong, Janet Paulsen, James C. Keith, George P. Vlasuk, Debra D. Pittman	45
7	Cloning and Characterization of an Uncoupling Protein Homolog: A Potential Molecular Mediator of Human Thermogenesis 1997 ·Diabetes ·Ruth E. Gimeno, Marlene Dembski, Xun Weng, Nanhua Deng, Andrew W. Shyjan, Carlos J. Gimeno, François Iris, Stephen J. Ellis, Elizabeth A. Woolf, Louis A. Tartaglia	439
8	Identification and localization of polycystin, the PKD1 gene product. 1996 ·Journal of Clinical Investigation ·Lin Geng, Yoav Segal, Bernard Peissel, Nanhua Deng, York Pei, Frank A. Carone, (unknown), (unknown), M. Schneider, Maria Ericsson, (unknown), Jing Zhou	157
9	Identification and expression cloning of a leptin receptor, OB-R breakdown → 1995 ·Cell ·Louis A. Tartaglia, Marlene Dembski, Xun Weng, Nanhua Deng, Janice Culpepper, René Devos, Grayson Richards, L. Arthur Campfield, Frederick Clark, Jim Deeds, Craig Muir, (unknown), A Moriarty, Karen J. Moore, John S. Smutko, (unknown), (unknown), (unknown), Robert I. Tepper	2845
10	Macrophage colony-stimulating factor (CSF-1) enhances invasiveness in CSF-1 receptor-positive carcinoma cell lines. 1992 ·PubMed ·Andrew E. Filderman, (unknown), Barry M. Kacinski, Nanhua Deng, Heinz G. Remold	84

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact